Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1976 Oct;58(4):950-4.
doi: 10.1172/JCI108548.

Inhibition of lymphoproliferation by hyperlipoproteinemic plasma

Inhibition of lymphoproliferation by hyperlipoproteinemic plasma

C C Waddell et al. J Clin Invest. 1976 Oct.

Abstract

Plasma for patients with primary type IV or V hyperlipoproteinemia inhibited [3H]thymidine incorporation by cultured mononuclear leukocytes. This previously unreported abnormality affected mononuclear leukocytes from patients with type IV or V hyperlipoproteinemia and from normal subjects. Patient cells incorporated [3H]thymidine normally when washed and incubated in medium containing normal plasma. Both spontaneous incorporation and stimulated incorporation in response to various mitogens and antigens were inhibited. The inhibitory effect was identified with the chylomicron and very low density lipoprotein fractions isolated from plasma and was concentration-dependent. Lectin used to stimulate cultured cells and [3H]thymidine used to measure responses were not bound to the lipoproteins in appreciable amounts. [3H]-Thymidine incorporation correlated well with morphologic evidence of lymphoproliferation. The mechanism of the inhibitory effect of type IV or V hyperlipoproteinemic plasma upon the response tested was not identified by may be related to interaction between lipoproteins and the cell membranes. We suggest that these lipoproteins may also interfere with the function of other cells.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Lab Clin Med. 1975 Jun;85(6):968-77 - PubMed
    1. J Clin Invest. 1975 Aug;56(2):467-75 - PubMed
    1. J Biol Chem. 1957 May;226(1):497-509 - PubMed
    1. Lancet. 1964 Oct 17;2(7364):842-3 - PubMed
    1. Lancet. 1972 Apr 22;1(7756):865-8 - PubMed

Publication types